• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Percentage of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month

Dictionary: Timely review of regulatory cases that come from the field is important as it allows FDA to take appropriate regulatory action such as issuance of a warning letter to the regulated industry. This can lead to a timely correction of problems in the industry resulting in a safer food supply.

Information is current as of September 30, 2021.

Fiscal Year - 2021

Skip graphic and jump to text data

TimeTargetPercentage
Oct 2020N/A75
Nov 2020N/A70
Dec 2020N/A100
Jan 2021N/A100
Feb 2021N/A92
Mar 2021N/A92
Apr 2021N/A50
May 2021N/A37
Jun 2021N/A71
Jul 2021N/A79
Aug 2021N/A88
Sep 2021N/A63

FY 2021 Total: 70%

Total number of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month

Fiscal Year - 2021
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2020N/A9
Nov 2020N/A7
Dec 2020N/A7
Jan 2021N/A5
Feb 2021N/A11
Mar 2021N/A12
Apr 2021N/A7
May 2021N/A10
Jun 2021N/A15
Jul 2021N/A11
Aug 2021N/A7
Sep 2021N/A5

FY 2021 Total: 106

Total number of regulatory cases referred to OFS in the month that are due within the month

Fiscal Year - 2021
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2020N/A12
Nov 2020N/A10
Dec 2020N/A7
Jan 2021N/A5
Feb 2021N/A12
Mar 2021N/A13
Apr 2021N/A14
May 2021N/A27
Jun 2021N/A21
Jul 2021N/A14
Aug 2021N/A8
Sep 2021N/A8

FY 2021 Total: 151

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.

-
-